AzTrials
AzTrials

Critical IllnessNCT06362525

Incidence of Episodes of (Dis)Connected Consciousness Among Emergency Patients Admitted in the Resuscitation Room

An observational study of Critical Illness and Near-Death Experience, run by University of Liege at 1 site in Belgium.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This observational study aims to describe the incidence of episodes of disconnected consciousness (including near-death experience (NDE)) and episodes of connected consciousness in patients admitted to the resuscitation room, who survived a critical condition and who meet at least one of these criteria during their… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
100 participants
Where
1 siteBelgium
Study dates
9 Oct 2023to 30 Sep 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All adult patients admitted in the resuscitation room

Who may be able to join

  • patients admitted in the resuscitation room of our university hospital
  • French speaking

Who cannot join

  • Refusal
  • Chronic disorder of consciousness
  • Deafness
  • Blindness
  • Dementia
  • Hemineglect
  • Aphasia

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Charlotte Martial, PhD contact

+3243233612

cmartial@uliege.be

Pauline Fritz, Ms contact

pauline.fritz@uliege.be

Belgium1 site, 1 recruiting
  • CHU of Liège

    Liège, 4000

    Recruiting

Other trials in Belgium

About this study

This observational study aims to describe the incidence of episodes of disconnected consciousness (including near-death experience (NDE)) and episodes of connected consciousness in patients admitted to the resuscitation room, who survived a critical condition and who meet at least one of these criteria during their stay in the resuscitation room: (1) deep sedation, (2) intubation, (3) cardiopulmonary resuscitation, or (4) (non-drug-induced) Glasgow Coma Scale score = 3. We also investigate the potential (neuro)physiological markers and biomarkers. In order to help determine the potential risk factors of such episodes, cognitive factors such as dissociative propensity are also investigated. Unexpected visual and auditory stimuli will be displayed. In addition, we assess the evolution of memory, as well as short- and long-term consequences on quality of life, anxiety, and attitudes towards care.

Memory of patients who did not meet the above-mentioned criteria are also investigated. A group of 15 healthy participants will be invited to test the stimuli display.

Finally, (neuro)physiological parameters of a subsample of dying patients are also investigated.

Keywords
Dream
Medical subject headings
Critical Illness, Death, Unconsciousness, Emergencies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Detection of potential episodes of disconnected consciousness

    near-death experience (using the Near-Death Experience Content scale); dream

    Measured: upon awakening/discharge from the resuscitation room (max 21 days after the admission in the room)

  2. Detection of potential episodes of connected consciousness

    explicit recall of environmental/external stimuli upon awakening

    Measured: upon awakening/discharge from the resuscitation room (max 21 days after the admission in the room)

Secondary outcomes (4)
  1. Risk factors

    (neuro)physiological marker; biomarker; cognitive factor

    Measured: in the resusctiation room admission

  2. Quality of life assessment

    The EuroQol five-dimension three-level questionnaire (EQ-5D-3L) comprises two sections. The first one is a five-question descriptive component which explores five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression). Each question has three possible answers, rated from 1 to 3 (no problems, some problems and extreme problems). The second section is a visual analogue scale (EQ VAS; 0 "worst imaginable health state" to 100 "best imaginable health state") about their current health state.

    Measured: at 6-month

  3. Memory content and evolution assessment

    The Memory Characteristics Questionnaire (MCQ). A total score can be derived summing all the 16 items (each on a 1-7 points Likert scale) and refers to as the amount of memory characteristics (i.e. higher total scores reflect greater amount of memory characteristics).

    Measured: at 1-month

  4. Detection of post-traumatic stress disorder (PTSD)

    The Posttraumatic Stress Disorder Checklist 5 (PCL-5). Its total score can range from 0 to 80 (scores of ≥31 suggest a probable diagnosis of PTSD)

    Measured: at 6-month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Apr 2024
  2. Study start9 Oct 2023
  3. Primary completion30 Sep 2025 (estimated)
  4. Study completion30 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06362525
Sponsor's protocol ID
2022-389
Status last verified
Jun 2023
First submitted
29 Aug 2023
Last updated
12 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data will be anonymized and shared among collaborators upon reasonable request and agreement

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness and Near-Death Experience, run by University of Liege at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Charlotte Martial, PhD (+3243233612, cmartial@uliege.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Detection of potential episodes of disconnected consciousness (time frame: upon awakening/discharge from the resuscitation room (max 21 days after the admission in the room)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in